{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:50:06Z","timestamp":1793407806543,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004593","name":"Universidad Aut\u00f3noma de Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijgc.2026.104803","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:36:20Z","timestamp":1781246180000},"page":"104803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glucagon-like peptide-1 receptor agonist and post-operative opioid consumption in gynecologic surgery"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1074-0229","authenticated-orcid":false,"given":"Paula","family":"Mateo-Kubach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5859-7936","authenticated-orcid":false,"given":"Gemma","family":"Mancebo Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8437-4733","authenticated-orcid":false,"given":"Kamilla L.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4366-2464","authenticated-orcid":false,"given":"Kyrstin","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Clara","family":"Sant\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5458-9417","authenticated-orcid":false,"given":"Tommaso","family":"Meschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6817-0693","authenticated-orcid":false,"given":"Heng-Cheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan P.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1049-6292","authenticated-orcid":false,"given":"Emily","family":"Rutledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro T.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10481","key":"10.1016\/j.ijgc.2026.104803_bib1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","article-title":"Global, regional, and national prevalence of adult overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021","volume":"405","author":"Ng","year":"2025","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.ijgc.2026.104803_bib2","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","article-title":"Projected U.S. State-Level prevalence of adult obesity and severe obesity","volume":"381","author":"Ward","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ijgc.2026.104803_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101351","article-title":"GLP-1 physiology informs the pharmacotherapy of obesity","volume":"57","author":"Drucker","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/j.ijgc.2026.104803_bib4","article-title":"Can GLP-1 be a target for reward system related disorders? A qualitative synthesis and systematic review analysis of studies on palatable food, drugs of abuse, and alcohol","volume":"14","author":"Eren-Yazicioglu","year":"2020","journal-title":"Front Behav Neurosci"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104803_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/bph.15677","article-title":"The role of glucagon-like peptide 1 (GLP-1) in addictive disorders","volume":"179","author":"Klausen","year":"2022","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104803_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/add.16679","article-title":"The association between glucose-dependent insulinotropic polypeptide and\/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: a real-world data analysis","volume":"120","author":"Qeadan","year":"2025","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.ijgc.2026.104803_bib7","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.3390\/ijms26115338","article-title":"GLP-1 analogues in the neurobiology of addiction: translational insights and therapeutic perspectives","volume":"26","author":"Marquez-Meneses","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.ijgc.2026.104803_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/17581869.2025.2536998","article-title":"GLP-1 agonists: a game changer in pain treatment and addiction","volume":"15","author":"Bade","year":"2025","journal-title":"Pain Manag"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104803_bib9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ygyno.2016.02.019","article-title":"A call for new standard of care in perioperative gynecologic oncology practice: impact of enhanced recovery after surgery (ERAS) programs","volume":"141","author":"Miralpeix","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104803_bib10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/ijgc-2019-000356","article-title":"Guidelines for perioperative care in gynecologic\/oncology: enhanced recovery after surgery (ERAS) Society recommendations-2019 update","volume":"29","author":"Nelson","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104803_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bpa.2019.07.016","article-title":"Postoperative pain management in the era of ERAS: an overview","volume":"33","author":"Joshi","year":"2019","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104803_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2025.102833","article-title":"Enhanced recovery in gynecologic surgery: institutional challenges and implementation framework","volume":"36","author":"Mateo-Kubach","year":"2025","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104803_bib13","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/AOG.0000000000006035","article-title":"Glucagon-like Peptide-1 receptor agonists in gynecologic surgery","volume":"146","author":"Hsu","year":"2025","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijgc.2026.104803_bib15","article-title":"Evaluating the impact of glucagon-like Peptide-1 receptor agonist receptor agonists on postoperative pain management in patients undergoing cancer surgery: a retrospective study","volume":"12","author":"Pennycuff","year":"2026","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104803_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/asj\/sjae241","article-title":"Semaglutide and postoperative outcomes in nondiabetic patients following body contouring surgery","volume":"45","author":"Lewis","year":"2025","journal-title":"Aesthetic Surg J"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104803_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35247","article-title":"Semaglutide and opioid overdose risk in patients with type 2 diabetes and opioid use disorder","volume":"7","author":"Wang","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104803_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13722-025-00618-2","article-title":"Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocol","volume":"20","author":"Freet","year":"2025","journal-title":"Addict Sci Clin Pract"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104803_bib19","doi-asserted-by":"crossref","DOI":"10.4212\/cjhp.3574","article-title":"Discharge opioid prescription and consumption following surgery: the POPCORN observational study","volume":"77","author":"Mohktari","year":"2024","journal-title":"Can J Hosp Pharm"},{"issue":"10","key":"10.1016\/j.ijgc.2026.104803_bib20","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1136\/ijgc-2020-001663","article-title":"Enhanced recovery for obese patients undergoing gynecologic cancer surgery","volume":"30","author":"Harrison","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"22","key":"10.1016\/j.ijgc.2026.104803_bib21","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3390\/cells13221857","article-title":"Semaglutide ameliorates diabetic neuropathic pain by inhibiting neuroinflammation in the spinal cord","volume":"13","author":"Lee","year":"2024","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104803_bib22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00125-023-06072-6","article-title":"Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy","volume":"67","author":"Dhanapalaratnam","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.ijgc.2026.104803_bib23","article-title":"The potential role of GLP-1 receptor agonists in substance use disorders - a systematic review","volume":"16","author":"V\u00f6lker","year":"2025","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104803_bib24","doi-asserted-by":"crossref","first-page":"E472","DOI":"10.1152\/ajpendo.00250.2023","article-title":"Brain access of incretins and incretin receptor agonists to their central targets relevant for appetite suppression and weight loss","volume":"326","author":"Buller","year":"2024","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104803_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133429","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","volume":"5","author":"Gabery","year":"2020","journal-title":"JCI Insight"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26003348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26003348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:49:11Z","timestamp":1785790151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X26003348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1048891X26003348"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104803","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide-1 receptor agonist and post-operative opioid consumption in gynecologic surgery","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of European Society of Gynaecological Oncology and the International Gynecologic Cancer Society.","name":"copyright","label":"Copyright"}],"article-number":"104803"}}